Lebwohl, M., Strober, B., Langley, R. G., Okubo, Y. ., Foley, P., Warren, R., Peterson, L., Cross, N., Wiegratz, S., Deherder, D., & Thaçi, D. (2024). Bimekizumab 3-year Safety and Tolerability in Moderate to Severe Plaque Psoriasis: Long-term Pooled Analysis from Five Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine, 8(1), s305. https://doi.org/10.25251/skin.8.supp.305